Search Results

Brazilian CancerThera Delegation Visits Uruguay's CUDIM to Advance Theranostics Cooperation in Oncology

Following the institutional partnership established between CEPID CancerThera and the Uruguayan Center for Molecular Imaging (CUDIM) in February this year, a Brazilian delegation visited Montevideo, Uruguay, from July 27 to 29 to advance the transformation of the memorandum of understanding into a concrete work plan. The visit focused on multicenter clinical trials, preclinical research, theranostics in oncology, and educational cooperation. During the visit, Brazilian researchers held working meetings with the CUDIM team, covering multiple aspects of oncology research development. CUDIM was represented by its General Director Alarico Rodriguez, as well as radiopharmacist and Technical Director of Radiopharmacy, Dr. Eduardo Osvaldo Savio Queve...

2026-08-20

Akiram Therapeutics and ITM Sign Lutetium-177 Supply Agreement to Support Radiopharmaceutical Development for Solid Tumors

Akiram Therapeutics, a Swedish clinical-stage biotechnology company, and ITM Isotope Technologies Munich SE, a German radiopharmaceutical biotechnology company, recently announced the signing of a supply agreement. Under the agreement, ITM will supply no-carrier-added lutetium-177 (nca Lu-177) to Akiram to support the clinical development of its targeted antibody-radionuclide conjugate, 177Lu-AKIR001 (AKIR001). AKIR001 is Akiram's lead radiopharmaceutical candidate, currently being investigated in clinical studies for the treatment of CD44v6-expressing solid tumors. The candidate combines the therapeutic radioisotope nca Lu-177 with a proprietary antibody targeting CD44v6. CD...

2026-08-20

Aomori Prefecture in Japan to Apply as Candidate Site for Nuclear Fusion Power Generation Demonstration Facility

On August 19, Soichiro Miyashita, Governor of Aomori Prefecture, stated that the prefecture will apply as a candidate site for a nuclear fusion power generation demonstration facility once relevant preparatory work is completed. Starlight Engine, a Japanese nuclear fusion startup, is currently soliciting candidate sites from prefectures and government-designated cities, with plans to conduct field surveys of promising candidates as early as this autumn. Starlight Engine plans to finalize the construction site by 2028, launch the FAST nuclear fusion power generation demonstration project in 2035, and conduct power generation demonstrations in 2038. The application deadline for site selection is October. Aomori Prefecture stated that it will consult with Rokkasho Village and, after preparing the application documents, formally submit the application.

2026-08-20

Automatic Radiation Environment Monitoring Station in Mianyang, Sichuan Put into Trial Operation, with Core Equipment and Systems Achieving Domestic Localization

Recently, the automatic radiation environment monitoring station located within the Nuclear Medical Health Industrial Park of the China (Mianyang) Science and Technology City was officially put into trial operation. As the first automatic radiation environment monitoring station in Sichuan Province to fully achieve domestic localization of core equipment and systems, it will provide radiation environment safety assurance for the development of the nuclear medical industry in the park through 24-hour uninterrupted automatic monitoring capabilities. At the automatic radiation environment monitoring station, operational data from equipment such as environmental γ dose rate monitors are updated in real time on monitoring screens. Compared with the previous approach that relied on manual on-site sampling and batch laboratory analysis, the automatic station enables continuous monitoring, reducing the time required to produce monitoring results from several days to the same day, thereby improving...

2026-08-20

Full-Life Technologies Completes Construction of Belgian Radiopharmaceutical Production Facility and Initiates Accelerator Commissioning

Full-Life Technologies (hereinafter referred to as "Full-Life"), a privately held, fully integrated, clinical-stage international radiopharmaceutical therapy company, announced on August 20 that its radiopharmaceutical production facility in Gembloux, Belgium, has completed construction and received authorization to commence accelerator commissioning and enter the initial ramp-up phase. (Full-Life Technologies Belgium Radiopharmaceutical Production Facility) This milestone marks a significant step forward in Full-Life's vertically integrated radioisotope production capabilities moving toward formal operational status. With the completion of facility construction, the company has entered the next phase of operational preparation, including accelerator installation, phased commissioning, and validation of critical safety and operational systems.

2026-08-20

Berkeley Lab Leads Development of Portable Active-Source Muon Imager

The U.S. Department of Energy's Lawrence Berkeley National Laboratory and Ideon Technologies have received funding from the DOE's Advanced Research Projects Agency-Energy (ARPA-E) to jointly develop a field-deployable active-source muon imaging technology through the Reliable Ore Characterization Using Cornerstone Sensing Technologies (ROCKS) program. The three-year project aims to enhance the detection and characterization of underground critical mineral resources. Image credit: Lawrence Berkeley National Laboratory. Muons are subatomic particles with strong penetrating capability. Previously, Ideon Technologies has used passive muons produced by cosmic rays in the atmosphere for ore body imaging in the mining sector, mapping mineral deposits and analyzing subsurface structures. However, passive muons primarily arrive from above, limiting detection angles; additionally, the natural flux is low—approximately one per square centimeter per minute—and imaging often requires days, weeks, or even months.

2026-08-20

Second Radiotherapy Linear Accelerator Commissioned at Buchholz Hospital in Germany

The second medical linear accelerator for cancer radiotherapy at Buchholz Hospital in the North Heath region of Germany has been commissioned. The device was activated by the hospital's radiotherapy department under the direction of Chief Physician Dr. Günter Bohlen, marking a further enhancement of local oncological radiotherapy capabilities. The management of Buchholz Hospital and Winsen Hospital, Dr. Franziska von Brunnig (third from right) and Dr. Martin Meyer (first from right), together with Chief Physician Dr. Günter Bohlen (second from right) and the radiotherapy team, posed for a photo at the official commissioning ceremony of the second linear accelerator at Buchholz Hospital. Photo: Buchholz-Winsen Hospital. According to available information, Buchholz Hospital...

2026-08-20

Yonsei Cancer Hospital in South Korea Expands Heavy Ion Radiotherapy Indications, Three Systems Operating Simultaneously

Yonsei Cancer Hospital in South Korea recently announced that it has further expanded the indications for heavy ion radiotherapy to include head and neck cancer, sarcoma, and recurrent rectal cancer. Since becoming the first hospital in South Korea to perform heavy ion radiotherapy for prostate cancer in 2023, the hospital has gradually expanded its treatment scope to cover pancreatic cancer, liver cancer, lung cancer, and other cancer types. Medical staff, including Proton Therapy Center Director Kim Woong-sub (left), are preparing for proton therapy. (Photo provided by Yonsei University Medical Center) Meanwhile, the hospital's second rotating heavy ion radiotherapy system has been fully commissioned. This brings the hospital to a configuration of one fixed-beam system and two rotating systems operating simultaneously. The hospital...

2026-08-20

West Engineering Delivers 30 Relay Protection and Automation Cabinets for Unit 2 of Akkuyu NPP

West Engineering has completed the next stage of equipment delivery for Unit 2 of the Akkuyu Nuclear Power Plant in Türkiye, shipping 30 relay protection and automation cabinets to the project site. The equipment will be used for the protection, monitoring, and control of critical electrical components of the power unit. The delivered equipment includes AZ-PZ cabinets for generating analog and discrete information, power supply unit protection device cabinets, power unit measurement device cabinets, synchronizing relay cabinets, generator switch control cabinets, electrical process recording cabinets, and control current distribution cabinets, among others. According to reports, this batch of nuclear facility equipment has been designed with high safety margins and fault tolerance in mind. The supplied relay protection and automation systems comply with relevant international standards, with a safety class of 3H/N, meeting the NP-001-15 standard; the quality assurance category is QA3, and the equipment has undergone multi-stage quality control from material and component selection to acceptance testing.

2026-08-20

Princeton Plasma Physics Laboratory to Validate Spherical Tokamak Fusion Path with NSTX-U

The Princeton Plasma Physics Laboratory (PPPL) is advancing research on the National Spherical Torus Experiment-Upgrade (NSTX-U), planning to use this largest spherical tokamak in the United States to assess the potential of compact tokamak configurations for future fusion power plants. The device is designed to become one of the most powerful spherical tokamaks in the world and will be used to study key issues such as high-temperature plasma confinement, heat transport, material performance, and real-time control. The image above shows the vacuum vessel and center column of the NSTX-U at the Princeton Plasma Physics Laboratory (PPPL). This device will help scientists determine the optimal shape for future fusion power plants...

2026-08-20

Installation of Cooling Tower Basins Completed at Rostov NPP Unit 4

The mechanical draft cooling tower project at Unit 4 of Russia's Rostov Nuclear Power Plant has recently completed the installation of all four basins, bringing the overall civil and installation readiness of the project to 80%. The facility will provide supplementary cooling capacity for Unit 4 during summer high temperatures and peak electricity demand in southern Russia. Rostov NPP is part of Rosenergoatom, the operator of Russian nuclear power plants, which is a member of the electric power division of Rosatom, Russia's state atomic energy corporation. Under the project plan, the new mechanical draft cooling tower will operate in conjunction with the existing natural draft evaporative cooling towers to enhance the unit's operational stability under high-temperature conditions. Rostov NPP's capital construction...

2026-08-20

CERN measures niobium-94 neutron capture for the first time, shedding new light on the mystery of molybdenum abundance in ancient stardust

The n_TOF collaboration at CERN recently reported that researchers have for the first time measured the probability of neutron capture by niobium-94. The results, published in Physical Review Letters, provide new experimental evidence for explaining the anomalous abundance of molybdenum-94 in presolar grains. The EAR2 facility in the n_TOF experiment at CERN produces intense neutron beams, opening new possibilities for nuclear research. Credit: CERN Niobium-94 is a niobium isotope containing 41 protons and 53 neutrons, occupying a critical juncture in the nuclear reaction chain that produces heavy elements in dying stars. Researchers are interested in it because niobium-94 is very close to molybdenum-94, differing by just one fewer proton and one more neutron. Under the high-temperature, high-pressure conditions inside stars, niobium-94 may either transform into molybdenum-94 through beta decay or form niobium-95 through neutron capture. The competition between these two reaction pathways directly affects scientists' understanding of the origin of molybdenum-94.

2026-08-20

Canada Approves Bruce Power Hot Cell Facility Operations, Strengthening Lutetium-177 Medical Isotope Supply Chain

Bruce Power has recently received approval from the Canadian Nuclear Safety Commission to operate its on-site hot cell facility for target carrier removal (TCR) work, a critical step in the production process of the medical isotope lutetium-177 (Lu-177). Lu-177 is used in the treatment of prostate cancer and is increasingly applied in targeted therapies for precision medicine. Under the approval, Bruce Power can perform the relevant processing steps on site, further streamlining the isotope production process, reducing transportation requirements, while helping to enhance operational safety, lower emissions, and strengthen Ontario's capabilities in the global medical isotope supply chain. The hot cell facility was completed earlier this year...

2026-08-20

Danube Water Levels Recover, Paks Nuclear Power Plant Expected to Resume Full-Capacity Operation

According to Hungarian sources on August 19, Peter Magyar stated that due to the recovery of Danube water levels, the Paks Nuclear Power Plant is expected to resume full-capacity operation by next weekend. Magyar noted that starting from Friday, August 28, the Paks Nuclear Power Plant will be ready for full-capacity operation. The recent rise of 15 to 20 centimeters in Danube water levels has created conditions for the plant to restore its output and has also eliminated the need for operators to shut down turbines again. Relevant experts plan to restart the turbines that have not yet resumed operation as soon as possible. Previously, due to historically low Danube water levels, the operation of the Paks Nuclear Power Plant, which relies on river water for cooling, was affected, and the plant's output once dropped to approximately 10% of full capacity.

2026-08-20

Wiley Launches Spectroscopy Analysis API Portfolio in the U.S., Enabling Rapid Identification of Unknown Compounds

HOBOKEN, N.J. — Wiley recently announced the launch of its spectroscopy analysis Application Programming Interface (API) portfolio, opening its spectral data, analytical algorithms, and predictive models to laboratories, instrument vendors, and software platforms to help users identify and verify unknown compounds faster within their own workflows. According to the company, Wiley has long been building scientific reference databases, with its spectral data applied across pharmaceuticals, forensics, environmental science, chemistry, food, and materials. The newly launched API portfolio aims to integrate these databases and analytical tools into more modern software environments, enabling laboratories to incorporate high-quality spectral information directly into existing...

2026-08-20